Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.46198 | 18 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.6965 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.45606 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.39974 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.62535 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.48625 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.452 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.39319 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.33085 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.43822 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.44641 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.44389 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.43462 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.44656 | 19 |